Brief: Weiss Asset Management Reports 11.79% Stake In Theravance Biopharma
12/04/2023 18:57
April 12 (Reuters) - Theravance Biopharma Inc TBPH.O :
* WEISS ASSET MANAGEMENT LP REPORTS 11.79% STAKE IN
THERAVANCE
BIOPHARMA INC AS OF APRIL 11 - SEC FILING
* WEISS ASSET MANAGEMENT LP - PURCHASED THERAVANCE
BIOPHARMA'S
SHARES FOR INVESTMENT, BASED ON BELIEF THAT SHARES ARE
"UNDERVALUED"
Further company coverage: TBPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions